Analysis of Blood Biomarkers in Patients with Chronic Obstructive Pulmonary Disease (COPD) and with Asthma-COPD Overlap (ACO)

References

• Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48(3):86–98. doi:10.1016/j.arbres.2011.10.007.
   PubMed Web of Science ®Google Scholar
• Barrecheguren M, Esquinas C, Miravitlles M. The asthma COPD overlap syndrome (ACOS). Opportunities and challenges. Curr Opin Pulm Med. 2015;21(1):74–79. doi:10.1097/MCP.0000000000000118.
   PubMed Web of Science ®Google Scholar
• GINA and Global Initiative for Chronic Obstructive Lung Disease (GOLD) [webpage on the Internet]. Asthma, COPD, and asthma-COPD overlap syndrome. GINA and Global Initiative for Chronic Obstructive Lung Disease; 2015 [accessed 2019 Oct 10]. Available from: http://www.goldcopd.org/asthma-copd-overlap.html
   Google Scholar
• Soler-Cataluña JJ, Novella L, Soler C, et al. Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap. Arch Bronconeumol. 2019. doi:10.1016/j.arbres.2019.08.023.[Epub ahead of print]
   Web of Science ®Google Scholar
• Plaza V, Alvarez F, Calle M, et al. Consensus on the asthma-COPD overlap syndrome (ACOS) between the Spanish COPD guidelines (GesEPOC) and the Spanish guidelines on the management of asthma (GEMA). Arch Bronconeumol. 2017;53(8):443–449.
   PubMed Web of Science ®Google Scholar
• Forget P, Khalifa C, Defour JP, et al. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12. doi:10.1186/s13104-016-2335-5.
   PubMedGoogle Scholar
• Fest J, Ruiter R, Ikram MA, et al. Reference values for white blood-cell-based inflammatory markers in the Rotterdam study: a population-based prospective cohort study. Sci Rep. 2018; 8(1):10566. doi:10.1038/s41598-018-28646-w.
   PubMed Web of Science ®Google Scholar
• Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12(1):127. doi:10.1186/1465-9921-12-127.
   PubMedGoogle Scholar
• Menezes AM, de Oca MM, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype COPD asthma. Chest. 2014;145(2):297–304. doi:10.1378/chest.13-0622.
   PubMed Web of Science ®Google Scholar
• Wurst KE, Rheault TR, Edwards L, et al. A comparison of COPD patients with and without ACOS in the ECLIPSE study. Eur Respir J. 2016;47(5):1559–1562. doi:10.1183/13993003.02045-2015.
   PubMed Web of Science ®Google Scholar
• Pérez de Llano L, Cosío BG, Miravitlles M, et al. Accuracy of a new algorithm to identify asthma-COPD overlap (ACO) patients in a cohort of patients with chronic obstructive airway disease. Arch Bronconeumol. 2018;54(4):198–204. doi:10.1016/j.arbres.2017.10.007.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053–1060. doi:10.1016/j.rmed.2013.03.007.
   PubMed Web of Science ®Google Scholar
• Christenson SA, Steiling K, van den Berge M, et al. Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):758–766. doi:10.1164/rccm.201408-1458OC.
   PubMed Web of Science ®Google Scholar
• Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3(6):435–442. doi:10.1016/S2213-2600(15)00106-X.
   PubMed Web of Science ®Google Scholar
• Nuñez A, Sarasate M, Loeb E, et al. Practical guide to the identification and diagnosis of asthma-COPD overlap (ACO). COPD J Chronic Obstruct Pulm Dis. 2019;16(1):1–7. doi:10.1080/15412555.2019.1575802.
   PubMed Web of Science ®Google Scholar
• Acartürk Tunçay E, Karakurt Z, Aksoy E, et al. Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker. Int J Chronic Obstruct Pulm Dis. 2017;12:3361–3370. doi:10.2147/COPD.S147261.
   PubMed Web of Science ®Google Scholar
• Yao C, Liu X, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chronic Obstruct Pulm Dis. 2017;12:2285–2290. doi:10.2147/COPD.S141760.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Makita H, Konno S, et al. Asthma-like features and clinical course of chronic obstructive pulmonary disease. An analysis from the Hokkaido COPD cohort study. Am J Respir Crit Care Med. 2016;194(11):1358–1365. doi:10.1164/rccm.201602-0353OC.
   PubMed Web of Science ®Google Scholar
• Aksoy E, Karakurt Z, Gungor S, et al. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes. Int J Chronic Obstruct Pulm Dis. 2018;13:2721–2730. doi:10.2147/COPD.S170353.
   PubMed Web of Science ®Google Scholar
• Fu JJ, McDonald VM, Gibson PG, et al. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res. 2014;6(4):316–324. doi:10.4168/aair.2014.6.4.316.
   PubMed Web of Science ®Google Scholar
• Nuñez A, Marras V, Harlander M, et al. Association between routine blood biomarkers and clinical phenotypes and exacerbations in chronic obstructive pulmonary disease. Int J Chronic Obstruct Pulm Dis. 2020;15:681–690. doi:10.2147/COPD.S240720.
   PubMed Web of Science ®Google Scholar